From early applications that saw the development of urine dipsticks, pregnancy and blood glucose testing, to lateral flow COVID devices, point-of-care testing has come far in the past 70 years. Here, Pathology in Practice Science Editor Brian Nation looks at a small selection of work focusing on POCT in the current literature.
Point-of-care testing: state-of-the-art and perspectives
Plebani M, Nichols JH, Luppa PB et al. Clin Chem Lab Med. 2024 Jun 17; 63 (1): 35–51. doi: 10.1515/cclm-2024-0675.
Point-of-care testing (POCT) is becoming an increasingly popular way to perform laboratory tests closer to the patient. This option has several recognised advantages, such as accessibility, portability, speed, convenience, ease of use, ever-growing test panels, lower cumulative healthcare costs when used within appropriate clinical pathways, better patient empowerment and engagement, and reduction of certain pre-analytical errors, especially those related to specimen transportation.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.